PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 27.95 CHF 4.1% Market Closed
Market Cap: 921.9m CHF
Have any thoughts about
PolyPeptide Group AG?
Write Note

Balance Sheet

Balance Sheet Decomposition
PolyPeptide Group AG

Current Assets 292.6m
Cash & Short-Term Investments 48.5m
Receivables 68.9m
Other Current Assets 175.2m
Non-Current Assets 372.3m
Long-Term Investments 6.2m
PP&E 334m
Intangibles 16.5m
Other Non-Current Assets 15.6m
Current Liabilities 183.6m
Accounts Payable 41.6m
Other Current Liabilities 142m
Non-Current Liabilities 121.4m
Long-Term Debt 68.5m
Other Non-Current Liabilities 52.9m

Balance Sheet
PolyPeptide Group AG

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
10
18
17
136
38
96
Cash Equivalents
10
18
17
136
38
96
Total Receivables
51
45
65
76
62
96
Accounts Receivables
42
34
56
68
49
79
Other Receivables
8
11
10
8
13
17
Inventory
72
73
94
113
145
129
Other Current Assets
8
7
3
6
7
6
Total Current Assets
141
143
180
332
252
327
PP&E Net
116
137
170
235
297
324
PP&E Gross
116
137
170
235
297
324
Accumulated Depreciation
116
117
129
135
157
175
Intangible Assets
11
12
13
14
16
16
Long-Term Investments
3
0
0
3
3
5
Other Long-Term Assets
13
13
14
10
8
17
Total Assets
284
N/A
305
+8%
376
+23%
595
+58%
576
-3%
689
+20%
Liabilities
Accounts Payable
15
18
28
28
46
61
Accrued Liabilities
12
10
13
17
12
15
Short-Term Debt
18
0
0
0
0
0
Current Portion of Long-Term Debt
6
1
12
4
5
47
Other Current Liabilities
12
27
48
54
33
54
Total Current Liabilities
64
56
102
104
96
176
Long-Term Debt
40
34
52
25
27
78
Deferred Income Tax
2
1
1
1
2
4
Other Liabilities
30
64
43
44
29
50
Total Liabilities
136
N/A
156
+14%
198
+27%
174
-12%
154
-11%
308
+100%
Equity
Common Stock
50
33
33
0
0
0
Retained Earnings
98
117
148
200
218
166
Additional Paid In Capital
2
2
2
213
203
203
Treasury Stock
0
0
0
1
14
10
Other Equity
2
3
6
9
14
22
Total Equity
148
N/A
149
+1%
178
+19%
421
+137%
422
+0%
381
-10%
Total Liabilities & Equity
284
N/A
305
+8%
376
+23%
595
+58%
576
-3%
689
+20%
Shares Outstanding
Common Shares Outstanding
33
33
33
33
33
33

See Also

Discover More